About: covid:PMC7091776

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7091776 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Elliott, M Ansell, S Gastineau, D Hogan, W Holtan, S Inwards, D Johnston, P Lacy, M Litzow, M Micallef, I Porrata, L
is schema:about of	named entity 'survival' named entity 'allogeneic' named entity 'dose' named entity 'chimerism' named entity 'RIC' named entity 'interquartile range' named entity 'HSCT' named entity 'HSCT' named entity 'prospective study' named entity 'CD34+' named entity 'HSCT' named entity 'fludarabine' named entity 'myeloid' named entity 'MDS' named entity 'GVHD' named entity 'autologous' named entity 'Kaplan-Meier' named entity 'myeloablative' named entity 'relapse' named entity 'serostatus' named entity 'HSCT' named entity 'high-risk' named entity 'allogeneic' named entity 'allogeneic' named entity 'lymphocyte' named entity 'MDS' named entity 'GVHD' named entity 'lymphoid' named entity 'allogeneic' named entity 'hematologic malignancies' named entity 'comorbidity' named entity 'RIC' named entity 'FISH' named entity 'malignancy' named entity 'GVHD' named entity 'CD34+' named entity 'HSCT' named entity 'allogeneic' named entity 'high-risk' named entity 'melphalan' named entity 'allogeneic' named entity 'lymphocyte' named entity 'multiple myeloma' named entity 'chemotherapy' named entity 'myelosuppressive' named entity 'RIC' named entity 'RIC' named entity 'hematopoietic' named entity 'GVHD' named entity 'neutrophil' named entity 'RIC' named entity 'prophylaxis' named entity 'AML' named entity 'neutrophil' named entity 'prognostic factor' named entity 'PFS' named entity 'refractory' named entity 'GVHD' named entity 'GVHD' named entity 'malignancy' named entity 'HSCT' named entity 'univariate analysis' named entity 'non-Hodgkin' named entity 'T-cell' named entity 'leukemia' named entity 'HSCT' named entity 'HSCT' named entity 'myeloid' named entity 'T-cell' named entity 'conditioning regimens' named entity 'relapse' named entity 'MDS' named entity 'immunomodulatory' named entity 'high-risk' named entity 'chimerism' named entity 'relapse' named entity 'RIC' named entity 'prophylaxis' named entity 'leukemia' named entity 'mononuclear cells' named entity 'hematologic malignancies' named entity 'solid tumors' named entity 'lymphoid malignancies' named entity 'Allogeneic' named entity 'chimerism' named entity 'prospective study' named entity 'polymorphic' named entity 'GVHD' named entity 'chimerism'

Attributes

Values

Creator

Elliott, M
Ansell, S
Gastineau, D
Hogan, W
Holtan, S
Inwards, D
Johnston, P
Lacy, M
Litzow, M
Micallef, I
Porrata, L

is schema:about of

named entity 'survival'
named entity 'allogeneic'
named entity 'dose'
named entity 'chimerism'
named entity 'RIC'
named entity 'interquartile range'
named entity 'HSCT'
named entity 'HSCT'
named entity 'prospective study'
named entity 'CD34+'
named entity 'HSCT'
named entity 'fludarabine'
named entity 'myeloid'
named entity 'MDS'
named entity 'GVHD'
named entity 'autologous'
named entity 'Kaplan-Meier'
named entity 'myeloablative'
named entity 'relapse'
named entity 'serostatus'
named entity 'HSCT'
named entity 'high-risk'
named entity 'allogeneic'
named entity 'allogeneic'
named entity 'lymphocyte'
named entity 'MDS'
named entity 'GVHD'
named entity 'lymphoid'
named entity 'allogeneic'
named entity 'hematologic malignancies'
named entity 'comorbidity'
named entity 'RIC'
named entity 'FISH'
named entity 'malignancy'
named entity 'GVHD'
named entity 'CD34+'
named entity 'HSCT'
named entity 'allogeneic'
named entity 'high-risk'
named entity 'melphalan'
named entity 'allogeneic'
named entity 'lymphocyte'
named entity 'multiple myeloma'
named entity 'chemotherapy'
named entity 'myelosuppressive'
named entity 'RIC'
named entity 'RIC'
named entity 'hematopoietic'
named entity 'GVHD'
named entity 'neutrophil'
named entity 'RIC'
named entity 'prophylaxis'
named entity 'AML'
named entity 'neutrophil'
named entity 'prognostic factor'
named entity 'PFS'
named entity 'refractory'
named entity 'GVHD'
named entity 'GVHD'
named entity 'malignancy'
named entity 'HSCT'
named entity 'univariate analysis'
named entity 'non-Hodgkin'
named entity 'T-cell'
named entity 'leukemia'
named entity 'HSCT'
named entity 'HSCT'
named entity 'myeloid'
named entity 'T-cell'
named entity 'conditioning regimens'
named entity 'relapse'
named entity 'MDS'
named entity 'immunomodulatory'
named entity 'high-risk'
named entity 'chimerism'
named entity 'relapse'
named entity 'RIC'
named entity 'prophylaxis'
named entity 'leukemia'
named entity 'mononuclear cells'
named entity 'hematologic malignancies'
named entity 'solid tumors'
named entity 'lymphoid malignancies'
named entity 'Allogeneic'
named entity 'chimerism'
named entity 'prospective study'
named entity 'polymorphic'
named entity 'GVHD'
named entity 'chimerism'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software